Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Preclinical Development: Overview01:28

Preclinical Development: Overview

5.5K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.5K
Drug Products: Biologics, Biosimilars and Interchangeables01:28

Drug Products: Biologics, Biosimilars and Interchangeables

114
Body:Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
114
Clinical Trials: Overview01:11

Clinical Trials: Overview

4.3K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.3K
Bioequivalence studies: Biowaivers01:13

Bioequivalence studies: Biowaivers

81
Body:In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
81
In Vitro Drug Release Testing: Overview, Development and Validation01:10

In Vitro Drug Release Testing: Overview, Development and Validation

115
In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
115
Clinically Relevant Drug Product Specifications: Methods of Establishment01:29

Clinically Relevant Drug Product Specifications: Methods of Establishment

89
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
89

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cervical strain elastography improves mid-trimester prediction of spontaneous preterm birth beyond cervical length: a single-center cohort study.

Frontiers in medicine·2026
Same author

Effect of Mechanical Polishing on Rice Flavor: Comparison and Exploration of Key Aroma Characteristics Components.

Foods (Basel, Switzerland)·2026
Same author

Clinical Practice Guideline for Spontaneous Isolated Superior Mesenteric Artery Dissection (2025 Edition).

Annals of vascular surgery·2026
Same author

Predictive Value of Imaging-Based Classifications for Conservative Management Failure in Isolated Superior Mesenteric Artery Dissection.

JACC. Asia·2026
Same author

Integrative Multi-Omics Analysis Identifies IL18R1 as a Circulating Prognostic Biomarker for Risk Stratification in Extensive-Stage Small Cell Lung Cancer.

Cancers·2026
Same author

[Seasonal Response of Ecological Environmental Quality to Climate Change on the Loess Plateau].

Huan jing ke xue= Huanjing kexue·2026
Same journal

[Study on <i>In Vitro</i> Chromosome Aberration Test for Nanomaterials and Medical Devices Containing Nanomaterials].

Zhongguo yi liao qi xie za zhi = Chinese journal of medical instrumentation·2026
Same journal

[Research on the Coordinated Mechanism of Medical Device Research and Evaluation in China and the United States].

Zhongguo yi liao qi xie za zhi = Chinese journal of medical instrumentation·2026
Same journal

[Research and Countermeasure Analysis on the Classification of Brain-Computer Interface Rehabilitation Medical Devices].

Zhongguo yi liao qi xie za zhi = Chinese journal of medical instrumentation·2026
Same journal

[Development of Portable Sleep Monitoring System].

Zhongguo yi liao qi xie za zhi = Chinese journal of medical instrumentation·2026
Same journal

[Design and Application of 3D-Printed Individualized Pelvic Prostheses].

Zhongguo yi liao qi xie za zhi = Chinese journal of medical instrumentation·2026
Same journal

[Study on Standardization Methods of Multi-Source Heterogeneous Data from ICU Medical Devices Based on openEHR].

Zhongguo yi liao qi xie za zhi = Chinese journal of medical instrumentation·2026
See all related articles

Related Experiment Video

Updated: Nov 19, 2025

Accessing the Cytotoxicity and Cell Response to Biomaterials
09:46

Accessing the Cytotoxicity and Cell Response to Biomaterials

Published on: July 8, 2021

4.1K

[Current Progress on Biological Evaluation for Medical Devices].

Chenghu Liu1, Yanping Shi1, Li Hou1

  • 1Shandong Quality and Inspection Center for Medical Devices;NMPA Key Laboratory for Quality Control of Pharmaceutical Packaging;NMPA Key Laboratory for Quality Control of Pharmaceutical Packaging;Shandong Provincial Key Laboratory of Biological Evaluation for Medical Devices, Jinan, 250101.

Zhongguo Yi Liao Qi Xie Za Zhi = Chinese Journal of Medical Instrumentation
|February 1, 2021
PubMed
Summary
This summary is machine-generated.

This study reviews biological evaluation for medical devices, covering life-cycle, toxicological risk, and packaging. It guides the use of ISO 10993-1:2018 for improved device safety and services.

Keywords:
biological evaluationmedical deviceregulatory sciencerisk management

More Related Videos

Biological Compatibility Profile on Biomaterials for Bone Regeneration
10:28

Biological Compatibility Profile on Biomaterials for Bone Regeneration

Published on: November 16, 2018

13.0K
An In Vitro Hemodynamic Loop Model to Investigate the Hemocytocompatibility and Host Cell Activation of Vascular Medical Devices
08:44

An In Vitro Hemodynamic Loop Model to Investigate the Hemocytocompatibility and Host Cell Activation of Vascular Medical Devices

Published on: August 21, 2020

7.5K

Related Experiment Videos

Last Updated: Nov 19, 2025

Accessing the Cytotoxicity and Cell Response to Biomaterials
09:46

Accessing the Cytotoxicity and Cell Response to Biomaterials

Published on: July 8, 2021

4.1K
Biological Compatibility Profile on Biomaterials for Bone Regeneration
10:28

Biological Compatibility Profile on Biomaterials for Bone Regeneration

Published on: November 16, 2018

13.0K
An In Vitro Hemodynamic Loop Model to Investigate the Hemocytocompatibility and Host Cell Activation of Vascular Medical Devices
08:44

An In Vitro Hemodynamic Loop Model to Investigate the Hemocytocompatibility and Host Cell Activation of Vascular Medical Devices

Published on: August 21, 2020

7.5K

Area of Science:

  • Medical Device Safety
  • Toxicology
  • Regulatory Science

Background:

  • Biological evaluation is crucial for medical device safety.
  • International standards like ISO 10993-1:2018 guide this process.
  • Understanding recent advancements is key for compliance.

Purpose of the Study:

  • To outline the evolving landscape of biological evaluation for medical devices.
  • To highlight key considerations in full life-cycle and toxicological risk assessment.
  • To provide guidance on applying ISO 10993-1:2018 effectively.

Main Methods:

  • Review of domestic and international progress in biological evaluation.
  • Focus on key aspects: life-cycle, toxicological risk, endpoints, and packaging.
  • Analysis of the updated ISO 10993-1:2018 standard.

Main Results:

  • Identification of critical areas in medical device biological evaluation.
  • Clarification of toxicological risk assessment and evaluation endpoints.
  • Emphasis on packaging material evaluation and life-cycle considerations.

Conclusions:

  • Adherence to updated standards like ISO 10993-1:2018 is essential.
  • A comprehensive approach to biological evaluation ensures device safety.
  • Improved understanding facilitates better service delivery in device evaluation.